Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Solid Tumors

Explore clinical trials studying Advanced or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

53 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Solid Tumors trial results

Completed

A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

NCT04866134

Conditions
Advanced or Metastatic Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Sarah Cannon Research Institute (HealthONE) Denver, Colorado, United States
  • Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States
  • Sarah Cannon Research Institute (Tennessee Oncology) Nashville, Tennessee, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Completed

A Study of MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

NCT05594043

Conditions
Advanced or Metastatic Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Sanford Cancer Center ( Site 0300) Sioux Falls, South Dakota, United States
  • Princess Margaret Cancer Centre ( Site 0101) Toronto, Ontario, Canada
  • Centre Hospitalier de l'Université de Montréal-Unit for Innovative Therapies ( Site 0100) Montreal, Quebec, Canada
  • Hôpitaux Universitaires de Genève (HUG) ( Site 0202) Geneva, Canton of Geneva, Switzerland
View Trial Details
Completed

A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)

NCT05017012

Conditions
Advanced or Metastatic Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • James Lind Centro de Investigación del Cáncer ( Site 0102) Temuco, Araucania, Chile
  • FALP-UIDO ( Site 0101) Santiago, Region M. de Santiago, Chile
  • Bradfordhill ( Site 0100) Santiago, Region M. de Santiago, Chile
  • Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 0021) Budapest, Pest County, Hungary
View all 22 locations
View Trial Details
Completed

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

NCT04843709

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Memorial Sloan Kettering 60th Street Outpatient Center New York, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • The Christ Hospital Cancer Center Cincinnati, Ohio, United States
View Trial Details
Completed

WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

NCT05678998

Conditions
Advanced or Metastatic Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Emory Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

NCT04381650

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • Stanford Cancer Institute (SCI) Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Completed

A Study of AK119 (Anti-CD73) in Combination With AK104 in Subjects With Advanced Solid Tumors

NCT04572152

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Blacktown Cancer and Haematology Centre (Blacktown Hospital) Blacktown, New South Wales, Australia
  • ICON Cancer Centre South Brisbane, Queensland, Australia
  • Ashford Cancer Centre Adelaide, South Australia, Australia
  • Monash Health Clayton, Victoria, Australia
View Trial Details
Completed

A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

NCT01928394

Conditions
Advanced or Metastatic Solid Tumors
Locations
  • Local Institution - 0047 Muscle Shoals, Alabama, United States
  • Local Institution - 0044 Aurora, Colorado, United States
  • Local Institution - 0015 New Haven, Connecticut, United States
  • Local Institution - 0046 Gainesville, Florida, United States
View all 38 locations
View Trial Details

Related conditions